| Financial Year |
March 31 2020 |
| Monetary Funds |
317,142,796.56 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
173,812,160.70 |
| Accounts Receivable |
538,355,438.59 |
| Advances to Suppliers |
231,464,077.54 |
| Other Receivables |
96,739,401.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
3,839,940.37 |
| Inventories |
830,412,629.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
279,320,300.89 |
| Total Current Assets |
3,356,818,888.01 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
316,042,841.02 |
| Long-term Equity Investment |
222,540,374.89 |
| Investment Properties |
-- |
| Fixed Assetes |
1,078,743,320.19 |
| Under-construction Projects |
166,200,307.20 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
113,359,496.23 |
| R&D expenses |
-- |
| Goodwill |
362,702,971.63 |
| Long-Term Deferred and Prepaid Expenses |
983,499.93 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
66,012,257.08 |
| Sub-Total of Non-Current Assets |
2,326,585,068.17 |
| Total Assets |
5,683,403,956.18 |
| Short-Term Loans |
7,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
321,378,461.67 |
| Accounts Payable |
1,152,675,451.12 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
49,045,911.14 |
| Taxes Payable |
3,343,432.25 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
766,698,458.16 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
17,671,903.39 |
| Other Current Liabilities |
242,698,689.00 |
| Sub-Total of Current Liabilities |
2,793,487,710.55 |
| Long-term Loans |
899,999,094.11 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
473,839,160.01 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,478,554,282.24 |
| Total Liabilities |
4,272,041,992.79 |
| Paid-In Capital(Or Share Stock) |
6,030,600,000.00 |
| Capital Surplus |
5,332,441,738.66 |
| Surplus Reserve |
506,342,014.21 |
| LESS:Treasury Stock |
19,020,048.00 |
| Undistributed Profits |
-10,339,825,467.60 |
| Minority Stockholder's Interest |
-93,289,930.50 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,504,651,893.89 |
| Owner's Equity（Stockholder's Equity） |
1,411,361,963.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,683,403,956.18 |
